NGEN
$3.33
-3.478%

NervGen Pharma Corp.
News & Events

Last updated: Nov 15, 2025, 6:57 PM ET

  1. NervGen Pharma Reports Second Quarter Financial Results and Provides Letter to Shareholders

    Newsfile AUG 26, 2025 7:30 AM EDT
    Announced unprecedented Phase 1b/2a topline results in chronic spinal cord injury NVG-291 is ...
    Read Article
  2. NervGen Pharma's NVG-291-R Demonstrates Significant Functional Recovery in Department of Defense-Sponsored Preclinical Models of Traumatic Hearing Loss and Peripheral Nerve Injury

    Newsfile AUG 21, 2025 7:30 AM EDT
    Demonstrated significant hearing restoration in blast-induced sensorineural hearing loss models ...
    Read Article
  3. NervGen Announces Leadership Transition to Support Strategic Growth and Expansion

    Newsfile JUL 17, 2025 7:30 AM EDT
    Chairman Dr. Adam Rogers Appointed Interim CEO Following Landmark Positive Chronic Spinal Cord In...
    Read Article
  4. NervGen Provides Quarterly "At-The-Market" Equity Program and Grant of Options Update

    Newsfile JUL 7, 2025 5:30 PM EDT
    Vancouver, British Columbia--(Newsfile Corp. - July 7, 2025) - NervGen Pharma Corp. (TSXV: ...
    Read Article
  5. NervGen Strengthens Board Leadership to Accelerate Clinical and Corporate Growth

    Newsfile JUL 3, 2025 4:41 PM EDT
    Dr. Adam Rogers appointed chair as company advances toward key milestones following positive topl...
    Read Article
  6. NervGen Announces Clinical Leadership Transition as NVG-291 Continues to Advance Toward Late-Stage Development and Regulatory Milestones

    Newsfile JUL 1, 2025 7:30 AM EDT
    Vancouver, British Columbia--(Newsfile Corp. - July 1, 2025) - NervGen Pharma Corp. (TSXV: NGEN)...
    Read Article
  7. NervGen Announces Appointment of Randall Kaye, MD to Chief Medical Advisor Role

    Newsfile JUN 18, 2025 7:30 AM EDT
    Vancouver, British Columbia--(Newsfile Corp. - June 18, 2025) - NervGen Pharma Corp. (TSXV: NGEN...
    Read Article
  8. Canadian Investment Regulatory Organization Trade Resumption - NGEN

    PR Newswire JUN 2, 2025 10:45 AM EDT
    Canadian Investment Regulatory Organization Trade Resumption - NGEN Canada NewsWire ...
    Read Article
  9. Canadian Investment Regulatory Organization Trade Resumption - NGEN

    Canada Newswire JUN 2, 2025 10:45 AM EDT
    Canadian Investment Regulatory Organization Trade Resumption - NGEN Canada NewsWire ...
    Read Article
  10. Canadian Investment Regulatory Organization Trading Halt - NGEN

    PR Newswire JUN 2, 2025 10:35 AM EDT
    Canadian Investment Regulatory Organization Trading Halt - NGEN Canada NewsWire ...
    Read Article

Upcoming Events

Get notified of NervGen Pharma Corp.’s latest announcements, news, and event dates.
  • Upcoming earnings announcement

    Not Available
  • Upcoming dividend payout

    Not Available
  • Upcoming stock splits

    Not Available